生命科学资讯

Merck looks to expand Welireg label following combo readouts with Keytruda, Lenvima

GLP-1 news galore; Top 100 venture investors; Doug Ingram to step down; and more

Ascendis wins FDA approval for achondroplasia drug, waits on EU action

Novartis, Takeda to enter next Medicare drug price negotiations

US International Trade Commission to take a closer look at Chinese biotech

Merck cuts more than 150 jobs at new Gardasil vaccine plant in North Carolina

CHMP recommends Moderna's flu-Covid shot and Novartis pill for hives

Generate:Biomedicines raises $400M IPO, CEO talks about AI's future in drug design

Ginkgo divests biosecurity arm; J&J's early prostate cancer data

Padcev-Keytruda combo delivers more positive data in bladder cancer

Novartis closes Avidity deal as rare heart disease spinout launches

Investors are pumping money into AI tools for health insurers

Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the future

DOJ urges Supreme Court to undo revival of Hikma ‘skinny label’ case

Doug Ingram’s force of will meets its match as Sarepta CEO plans to depart

FDA probes internal Prasad complaints with outside help

Boehringer wins accelerated approval for first-line use of lung cancer drug

Senate hearing raises FDA-related concerns for new rare disease drugs

Viatris plans to lay off up to 10% of staff, discloses Indian factory fire

Why did my doctor push Grail’s dubious cancer test?